 |
|
|
|
September 2008 Cover
|
|
One of the stars in the HIV drug development pipeline may have winked out: Despite promising early study results, a unique drug known as KP-1461 was -- surprisingly -- found to have almost no HIV-fighting ability in its latest clinical trial. Further study of KP-1461 has been halted while researchers try to figure out how the drug, which appeared to virtually eliminate all traces of HIV in initial lab tests, had little effect when tested in HIV-positive people.
from Project Inform
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
